Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00810628 · ClinicalTrials.gov registry record · NA

Cognitive Behavioral Therapy for Depression in Parkinson's Disease

A NA study, sponsored by Oregon Health and Science University.

Terminated
Registry status
NA
Development phase
12
Enrollment target

NCT00810628 is a NA study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00810628, a NA study, was terminated before completion, sponsored by Oregon Health and Science University.

TERMINATED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

The purpose of this pilot program is to develop and evaluate a new treatment program for depression in Parkinson's disease (PD). The treatment uses Cognitive Behavior Therapy(CBT)to teach patients how to become more aware of their thoughts and feelings and to change thinking patterns and behaviors that may be related to depressive symptoms. This is the first time that this treatment has been used in a group setting for depression in PD. Target population is patients in the Movement Disorders Clinic at Oregon Health \& Science University who have Parkinson's disease and mild to moderate depression.

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2009-01
Est. Completion 2009-12
Phase NA

What the Registry Record Tells You About NCT00810628

The ClinicalTrials.gov registry entry for NCT00810628 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.

NCT00810628 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00810628 about?

NCT00810628 is a clinical study titled "Cognitive Behavioral Therapy for Depression in Parkinson's Disease". The purpose of this pilot program is to develop and evaluate a new treatment program for depression in Parkinson's disease (PD). The treatment uses Cognitive Behavior Therapy(CBT)to teach patients how to become more aware of their thoughts and feelings and to change thinking patterns and behaviors t...

What is the current status of trial NCT00810628?

This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2009-01. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00810628?

The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00810628?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.